Holdings (Monthly)
Guide ↗
Tema Oncology ETF
· Tema ETF Trust| # | Name | Ticker | Since | Shares | Value | % Port | Cat |
|---|---|---|---|---|---|---|---|
| 1 | Revolution Medicines Inc | RVMD | Feb 2026 | 98,581 | $10.1M | 6.29% | EC |
| 2 | Novartis AG | NOVN | Feb 2026 | 46,684 | $7.9M | 4.96% | EC |
| 3 | Bridgebio Pharma Inc | BBIO | Feb 2026 | 114,318 | $7.6M | 4.75% | EC |
| 4 | AstraZeneca PLC | AZN | Feb 2026 | 35,320 | $7.4M | 4.63% | EC |
| 5 | Eli Lilly & Co | LLY | Feb 2026 | 6,565 | $6.9M | 4.32% | EC |
| 6 | Bristol-Myers Squibb Co | BMY | Feb 2026 | 108,187 | $6.7M | 4.22% | EC |
| 7 | Roche Holding AG | RHHBY | Feb 2026 | 108,952 | $6.5M | 4.06% | EC |
| 8 | Merck & Co Inc | MRK | Feb 2026 | 49,630 | $6.1M | 3.84% | EC |
| 9 | Arcellx Inc | ACLX | Feb 2026 | 48,346 | $5.5M | 3.44% | EC |
| 10 | Cogent Biosciences Inc | COGT | Feb 2026 | 135,358 | $5.3M | 3.29% | EC |
| 11 | Nuvalent Inc | NUVL | Feb 2026 | 49,239 | $5.0M | 3.14% | EC |
| 12 | Genmab A/S | GMAB | Feb 2026 | 169,724 | $5.0M | 3.13% | EC |
| 13 | Immunome Inc | IMNM | Feb 2026 | 195,451 | $4.3M | 2.67% | EC |
| 14 | Johnson & Johnson | JNJ | Feb 2026 | 16,257 | $4.0M | 2.53% | EC |
| 15 | Celcuity Inc | CELC | Feb 2026 | 35,371 | $4.0M | 2.47% | EC |
| 16 | Amgen Inc | AMGN | Feb 2026 | 10,122 | $3.9M | 2.46% | EC |
| 17 | AbbVie Inc | ABBV | Feb 2026 | 16,712 | $3.9M | 2.43% | EC |
| 18 | Exelixis Inc | EXEL | Feb 2026 | 79,639 | $3.5M | 2.19% | EC |
| 19 | Ideaya Biosciences Inc | IDYA | Feb 2026 | 89,238 | $2.9M | 1.80% | EC |
| 20 | BeOne Medicines Ltd | ONC | Feb 2026 | 8,960 | $2.8M | 1.78% | EC |
| 21 | Syndax Pharmaceuticals Inc | SNDX | Feb 2026 | 127,353 | $2.8M | 1.73% | EC |
| 22 | CG oncology Inc | CGON | Feb 2026 | 45,885 | $2.7M | 1.69% | EC |
| 23 | Zai Lab Ltd | ZLAB | Feb 2026 | 121,279 | $2.3M | 1.46% | EC |
| 24 | Erasca Inc | ERAS | Feb 2026 | 169,487 | $2.3M | 1.45% | EC |
| 25 | Zymeworks Inc | ZYME | Feb 2026 | 96,723 | $2.3M | 1.41% | EC |
| 26 | Legend Biotech Corp | LEGN | Feb 2026 | 115,409 | $2.2M | 1.37% | EC |
| 27 | Nuvation Bio Inc | NUVB | Feb 2026 | 362,046 | $2.1M | 1.34% | EC |
| 28 | Halozyme Therapeutics Inc | HALO | Feb 2026 | 29,868 | $2.1M | 1.30% | EC |
| 29 | Chugai Pharmaceutical Co Ltd | 4519 | Feb 2026 | 30,652 | $2.1M | 1.28% | EC |
| 30 | Summit Therapeutics Inc | SMMT | Feb 2026 | 110,918 | $1.8M | 1.15% | EC |
| 31 | AnaptysBio Inc | ANAB | Feb 2026 | 28,657 | $1.6M | 0.99% | EC |
| 32 | Nurix Therapeutics Inc | NRIX | Feb 2026 | 97,555 | $1.6M | 0.97% | EC |
| 33 | Regeneron Pharmaceuticals Inc | REGN | Feb 2026 | 1,982 | $1.5M | 0.97% | EC |
| 34 | Corvus Pharmaceuticals Inc | CRVS | Feb 2026 | 82,148 | $1.5M | 0.94% | EC |
| 35 | UroGen Pharma Ltd | URGN | Feb 2026 | 67,164 | $1.5M | 0.91% | EC |
| 36 | Relay Therapeutics Inc | RLAY | Feb 2026 | 142,040 | $1.5M | 0.91% | EC |
| 37 | Gilead Sciences Inc | GILD | Feb 2026 | 9,272 | $1.4M | 0.86% | EC |
| 38 | Olema Pharmaceuticals Inc | OLMA | Feb 2026 | 56,608 | $1.4M | 0.86% | EC |
| 39 | Day One Biopharmaceuticals Inc | DAWN | Feb 2026 | 121,928 | $1.3M | 0.81% | EC |
| 40 | Argenx SE | ARGX | Feb 2026 | 1,663 | $1.3M | 0.80% | EC |
| 41 | Terns Pharmaceuticals Inc | TERN | Feb 2026 | 28,018 | $1.2M | 0.74% | EC |
| 42 | First American Treasury Obliga | FXFXX | Feb 2026 | 1,026,901 | $1.0M | 0.64% | STIV |
| 43 | Xencor Inc | XNCR | Feb 2026 | 76,928 | $982K | 0.61% | EC |
| 44 | Tyra Biosciences Inc | TYRA | Feb 2026 | 28,438 | $947K | 0.59% | EC |
| 45 | Guardant Health Inc | GH | Feb 2026 | 10,008 | $940K | 0.59% | EC |
| 46 | Arcus Biosciences Inc | RCUS | Feb 2026 | 45,953 | $936K | 0.59% | EC |
| 47 | ArriVent Biopharma Inc | AVBP | Feb 2026 | 40,743 | $936K | 0.59% | EC |
| 48 | Immunocore Holdings PLC | IMCR | Feb 2026 | 28,275 | $913K | 0.57% | EC |
| 49 | HUTCHMED China Ltd | HCM | Feb 2026 | 62,129 | $890K | 0.56% | EC |
| 50 | Monte Rosa Therapeutics Inc | GLUE | Feb 2026 | 45,524 | $808K | 0.51% | EC |
| 51 | Cullinan Therapeutics Inc | CGEM | Feb 2026 | 47,065 | $730K | 0.46% | EC |
| 52 | Compass Therapeutics Inc | CMPX | Feb 2026 | 127,476 | $720K | 0.45% | EC |
| 53 | Janux Therapeutics Inc | JANX | Feb 2026 | 47,193 | $642K | 0.40% | EC |
| 54 | Natera Inc | NTRA | Feb 2026 | 3,049 | $634K | 0.40% | EC |
| 55 | Arvinas Inc | ARVN | Feb 2026 | 45,326 | $601K | 0.38% | EC |
| 56 | ORIC Pharmaceuticals Inc | ORIC | Feb 2026 | 35,407 | $476K | 0.30% | EC |